🇺🇸 FDA
Patent

US 10961298

Monoclonal antibodies for treatment of microbial infections

granted A61KA61K2039/505

Quick answer

US patent 10961298 (Monoclonal antibodies for treatment of microbial infections) held by The Government of the United States, represented by the Secretary of the Army expires Mon Mar 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Government of the United States, represented by the Secretary of the Army
Grant date
Tue Mar 30 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K2039/505